Market revenue in 2023 | USD 22.4 million |
Market revenue in 2030 | USD 85.7 million |
Growth rate | 21.2% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Banks |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Therapeutics, Tools, Banks, Services |
Key market players worldwide | AstraZeneca PLC, Roche Holding AG, Integra Lifesciences Holdings Corp, Astellas Pharma Inc, Cook Group, Bayer AG, Pfizer Inc, Merck KGaA, Abbott Laboratories, Vericel Corp, Novartis AG ADR, GlaxoSmithKline |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regenerative medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 76.79% in 2023. Horizon Databook has segmented the UAE regenerative medicine market based on therapeutics, tools, banks, services covering the revenue growth of each sub-segment from 2018 to 2030.
Several initiatives being undertaken by various organizations to boost the biotechnology and biopharmaceutical sectors in the country are anticipated to support market growth in the UAE. The Dubai Biotechnology and Research Park (DuBiotech) is a science & business park devoted to the biotechnology sector, which facilitates government-funded R&D activities. DuBiotech’s infrastructure includes R&D labs and biotech-related educational & research institutions, which foster the creation of new technologies and diagnostics.
Furthermore, with growing economic strength and the rising dominance of the country in the Middle East, its biomanufacturing capabilities are expected to grow in the near future and fuel market growth. Furthermore, the rising importance of regenerative medicine therapy in the management of lifethreatening conditions and rising number of stem cell centers in the country are supporting the country’s market.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into UAE regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account